Showing 1 - 10 of 52
This paper examines the role of liability for past environmental contamination in the privatization processes of … Central and Eastern Europe. The theoretical section establishes a link between a risk-averse investor’s amount of information … faces less risk; therefore, the investor’s risk premium falls and the investor’s bid rises. This link generates four …
Persistent link: https://www.econbiz.de/10005504606
) differences in the liability of the lender and the borrower for losses; and (ii) differences in the information available to the …
Persistent link: https://www.econbiz.de/10005792003
When firms undertake activities which are environmentally risky, the divergence between social and private incentives to exert safety care requires public intervention. This control occurs both through ex ante regulation and ex post legal investigation. We delineate the respective scopes of...
Persistent link: https://www.econbiz.de/10005123764
pharmaceuticals, specifically drug reformulation regulatory gaming. …
Persistent link: https://www.econbiz.de/10009205060
pharmaceuticals. We challenge this orthodox view and show, to the contrary, that the pace of innovation often is faster in a world …
Persistent link: https://www.econbiz.de/10005666872
This paper addresses the relationship between patent protection and investment in the development of new pharmaceutical treatments. The TRIPS Agreement, which specifies minimum levels of intellectual property protection for countries in the World Trade Organization, has increased levels of...
Persistent link: https://www.econbiz.de/10009002387
the hypothesis that innovation in pharmaceuticals is becoming more difficult and expensive over time, as costs of …
Persistent link: https://www.econbiz.de/10009003149
creating an internal market for pharmaceuticals can be analysed. In a model of third-degree price discrimination, arbitrage … Market in pharmaceuticals are ambiguous, since a movement from segmented and price-controlled markets towards integrated …
Persistent link: https://www.econbiz.de/10005114350
risk, then a monpolist would have more difficulty extracting surplus with a preventive than with a treatment because … treatment consumers, having contracted the disease, no longer differ in disease risk. We show that the ratio of preventive to …. Calibrations for HIV and heart attacks based on risk factors in the U.S. population suggest that the distribution of disease risk …
Persistent link: https://www.econbiz.de/10011196028
We provide a method allowing to identify margins in an oligopoly price competition game when prices may not be freely chosen in some markets, for example due to regulation. We use our identification strategy to study the effects of regulatory constraints in the pharmaceutical industry, which is...
Persistent link: https://www.econbiz.de/10011083879